CMA drops anti-competitive case against MSD
The CMA has closed its investigation into a suspected anti-competitive discount scheme by MSD, findings no grounds for action.
Read More
Tag: anti-competetive
- Transgene completes randomisation in phase 2 trial of tg4050
- Bayer wins MHRA approval for Kerendia in heart failure
- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
- Kainova expands DT 7012 trial into Europe
- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
